| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.22 | 0.2 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.066 | 0.2 |